239 related articles for article (PubMed ID: 25728022)
21. Synthesis and anticancer activity of novel C6-piperazine substituted purine steroid-nucleosides analogues.
Huang LH; Xu HD; Yang ZY; Zheng YF; Liu HM
Steroids; 2014 Apr; 82():1-6. PubMed ID: 24378780
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and cytotoxic evaluation of novel 2-(4-(2,2,2-trifluoroethoxy)-3-methylpyridin-2-ylthio)-1H-benzo[d]imidazole derivatives.
Ranganatha SR; Kavitha CV; Vinaya K; Prasanna DS; Chandrappa S; Raghavan SC; Rangappa KS
Arch Pharm Res; 2009 Oct; 32(10):1335-43. PubMed ID: 19898794
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, quantum chemical studies and biological activity evaluation of pyrazole-benzimidazole derivatives as potent Aurora A/B kinase inhibitors.
Zheng Y; Zheng M; Ling X; Liu Y; Xue Y; An L; Gu N; Ji M
Bioorg Med Chem Lett; 2013 Jun; 23(12):3523-30. PubMed ID: 23664099
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and docking studies of novel antitumor benzimidazoles.
Omar MA; Shaker YM; Galal SA; Ali MM; Kerwin SM; Li J; Tokuda H; Ramadan RA; El Diwani HI
Bioorg Med Chem; 2012 Dec; 20(24):6989-7001. PubMed ID: 23123017
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis and docking studies of benzimidazole derivatives as potential EGFR inhibitors.
Celik İ; Ayhan-Kılcıgil G; Guven B; Kara Z; Gurkan-Alp AS; Karayel A; Onay-Besikci A
Eur J Med Chem; 2019 Jul; 173():240-249. PubMed ID: 31009910
[TBL] [Abstract][Full Text] [Related]
26. Synthesis, in vitro antitumor activity, dihydrofolate reductase inhibition, DNA intercalation and structure-activity relationship studies of 1,3,5-triazine analogues.
Singla P; Luxami V; Paul K
Bioorg Med Chem Lett; 2016 Jan; 26(2):518-523. PubMed ID: 26670841
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, crystal structure and biological activities of copper(II) complexes with chelating bidentate 2-substituted benzimidazole ligands.
Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Grünert R; Gdaniec M; Tabin P
J Inorg Biochem; 2006 Aug; 100(8):1389-98. PubMed ID: 16740312
[TBL] [Abstract][Full Text] [Related]
28. Solvent-free synthesis and anticancer activity evaluation of benzimidazole and perimidine derivatives.
Kumar A; Banerjee S; Roy P; Sondhi SM; Sharma A
Mol Divers; 2018 Feb; 22(1):113-127. PubMed ID: 29143160
[TBL] [Abstract][Full Text] [Related]
29. First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.
Bonham S; O'Donovan L; Carty MP; Aldabbagh F
Org Biomol Chem; 2011 Oct; 9(19):6700-6. PubMed ID: 21808774
[TBL] [Abstract][Full Text] [Related]
30. Novel purine benzimidazoles as antimicrobial agents by regulating ROS generation and targeting clinically resistant Staphylococcus aureus DNA groove.
Wang YN; Bheemanaboina RRY; Cai GX; Zhou CH
Bioorg Med Chem Lett; 2018 May; 28(9):1621-1628. PubMed ID: 29598912
[TBL] [Abstract][Full Text] [Related]
31. Benzimidazole derivatives related to 2,3-acrylonitriles, benzimidazo[1,2-a]quinolines and fluorenes: synthesis, antitumor evaluation in vitro and crystal structure determination.
Hranjec M; Pavlović G; Marjanović M; Kralj M; Karminski-Zamola G
Eur J Med Chem; 2010 Jun; 45(6):2405-17. PubMed ID: 20207049
[TBL] [Abstract][Full Text] [Related]
32. Benzimidazole clubbed with triazolo-thiadiazoles and triazolo-thiadiazines: new anticancer agents.
Husain A; Rashid M; Shaharyar M; Siddiqui AA; Mishra R
Eur J Med Chem; 2013 Apr; 62():785-98. PubMed ID: 23333063
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of novel pyrimidine-benzimidazol hybrids as potential anticancer agents.
Shao KP; Zhang XY; Chen PJ; Xue DQ; He P; Ma LY; Zheng JX; Zhang QR; Liu HM
Bioorg Med Chem Lett; 2014 Aug; 24(16):3877-81. PubMed ID: 25001482
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and bioevaluation of N-trisubstituted pyrimidine derivatives as potent aurora A kinase inhibitors.
Luo Y; Deng YQ; Wang J; Long ZJ; Tu ZC; Peng W; Zhang JQ; Liu Q; Lu G
Eur J Med Chem; 2014 May; 78():65-71. PubMed ID: 24681066
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and Antitumor Evaluation of Novel 5-Hydrosulfonyl-1H-benzo[d]imidazol-2(3H)-one Derivatives.
Ouyang G; Tong R; Li J; Bai L; Ouyang L; Duan X; Li F; He P; Shi J; He Y
Molecules; 2016 Apr; 21(4):516. PubMed ID: 27104509
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and in vitro anti-proliferative activity of 4,6-quinazolinediamines as potent EGFR-TK inhibitors.
Mowafy S; Farag NA; Abouzid KA
Eur J Med Chem; 2013 Mar; 61():132-45. PubMed ID: 23142066
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, in vitro evaluation and molecular modelling of naphthalimide analogue as anticancer agents.
Verma M; Luxami V; Paul K
Eur J Med Chem; 2013 Oct; 68():352-60. PubMed ID: 23994328
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, in vitro and in vivo antitumor and antiviral activity of novel 1-substituted benzimidazole derivatives.
Shaker YM; Omar MA; Mahmoud K; Elhallouty SM; El-Senousy WM; Ali MM; Mahmoud AE; Abdel-Halim AH; Soliman SM; El Diwani HI
J Enzyme Inhib Med Chem; 2015; 30(5):826-45. PubMed ID: 25567722
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and biological evaluation of novel benzimidazole amidines as potent multi-target inhibitors for the treatment of non-small cell lung cancer.
Bistrović A; Krstulović L; Harej A; Grbčić P; Sedić M; Koštrun S; Pavelić SK; Bajić M; Raić-Malić S
Eur J Med Chem; 2018 Jan; 143():1616-1634. PubMed ID: 29133046
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and biological evaluation of novel benzimidazole-2-substituted phenyl or pyridine propyl ketene derivatives as antitumour agents.
Wu LT; Jiang Z; Shen JJ; Yi H; Zhan YC; Sha MQ; Wang Z; Xue ST; Li ZR
Eur J Med Chem; 2016 May; 114():328-36. PubMed ID: 27017265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
